Pitfalls and unmet needs of transition in epilepsy: Understanding the adult neurologist perspective

Pietro Mattioli1, Maria Margherita Mancardi2, Alessandra Ferrari3

  • 1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy; Division of Clinical Neurophysiology and Epilepsy Centre, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Epilepsy & Behavior : E&B
|October 18, 2024
PubMed

Insights

Transitioning young epilepsy patients to adult care is complex. Adult neurologists find it challenging, highlighting needs for shared action plans and improved training in childhood epilepsies for better outcomes.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Healthcare Transition

Background:

  • The transition from pediatric to adult epilepsy care is crucial for optimal outcomes in young people.
  • Failure in this transition process is linked to adverse epilepsy, cognitive, and behavioral results.
  • Despite growing research interest, clinical transition remains a sensitive issue for adult neurologists.

Purpose of the Study:

  • To explore the challenges and unmet needs of epilepsy care transition from the perspective of adult neurologists.
  • To identify specific difficulties adult neurologists encounter during the patient transition process.
  • To gather insights for improving the transition of care for young individuals with epilepsy.

Main Methods:

  • A survey was distributed to adult neurologists to gather their perspectives on the transition process.
  • The survey assessed whether transition is perceived as problematic, its impact on clinical practice, and identified key issues.
  • The survey also aimed to elicit suggestions for enhancing the transition of care.

Main Results:

  • Adult neurologists perceive the transition process as complex and challenging.
  • Key issues identified include the need for a shared action plan between pediatric and adult care providers.
  • There is a recognized need for enhanced training in childhood epilepsies for adult neurologists.

Conclusions:

  • The transition of epilepsy care requires a collaborative approach involving both pediatric and adult neurologists.
  • Multidisciplinary team meetings are suggested as a valuable component of the transition process.
  • Improving adult neurologists' knowledge of childhood epilepsies is essential for successful care transitions.

Related Concept Videos

Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
178
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
147
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
304
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
285
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
336